The impact of the COVID-19 epidemic on tuberculosis control in China
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. METHODS: Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regular (4 additional weeks). Data from 2017-2019 were used as baseline. FINDINGS: week of the intensive period but took significantly longer to rebound in 2020 compared with baseline. The percentages of TB patients undergoing sputum examination within one week after 2 months treatment and full treatment course in the intensive period were most affected and decreased by 8% in comparison with control period. 75•2% (221/294) of counties reallocated CDC and primary health care workers to fight the COVID-19 epidemic, 26•9% (725/2694) of TB patients had postponed or missed their follow-up examinations due to travel restrictions and fear of contracting COVID-19. INTERPRETATION: In the short term, the COVID-19 epidemic mostly affected TB notification and follow-up examinations in China, which may lead to a surge of demand for TB services in the near future. To cope with this future challenge, an emergency response mechanism for TB should be established. FUNDING: National Health Commission of China-Bill & Melinda Gates Foundation TB Collaboration project (OPP1137180).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tian, H., Liu, Y., Li, Y., Wu, C.-H., Chen, B., Kraemer, M. U. G., Li, B., Cai, J., Xu, B., Yang, Q., et al. (2020) · Science · doi:10.1126/science.abb6105 · Cited by 2,010
Pan, A., Liu, L., Wang, C., Guo, H., Hao, X., Wang, Q., Huang, J., He, N., Yu, H., Lin, X., et al. (2020) · JAMA · doi:10.1001/jama.2020.6130 · Cited by 1,931
Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China
Zhang, J., Litvinova, M., Liang, Y., Wang, Y., Wang, W., Zhao, S., Wu, Q., Merler, S., Viboud, C., Vespignani, A., et al. (2020) · Science · doi:10.1126/science.abb8001 · Cited by 1,107
Electronic recording and reporting system for tuberculosis in China: experience and opportunities
Huang, F., Cheng, S., Du, X., Chen, W., Scano, F., Falzon, D., & Wang, L. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-002001 · Cited by 83
Self-citation
Cited by
The impact of COVID-19 on TB: a review of the data
McQuaid, C. F., Vassall, A., Cohen, T., Fiekert, K., COVID/TB Modelling Working Group *, & White, R. G. (2021) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.21.0148 · Cited by 319
Dheda, K., Perumal, T., Moultrie, H., Perumal, R., Esmail, A., Scott, A. J., Udwadia, Z., Chang, K. C., Peter, J., Pooran, A., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00092-3 · Cited by 292
Timing the SARS-CoV-2 index case in Hubei Province
Pekar, J., Worobey, M., Moshiri, N., Scheffler, K., & Wertheim, J. O. (2021) · Science · doi:10.1126/science.abf8003 · Cited by 156
“Nov 17 Strict I-only None 7 (1-15) 13 (4-31) 24 (8-271)”
InfluentialScientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis
Reid, M., Agbassi, Y. J. P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01379-x · Cited by 87
Self-citationAnalysis of epidemiological characteristics of extrapulmonary tuberculosis from South-Central China
Yu, Y., Xiang, Y., Liu, H., Yang, S., Li, M., Liu, B., Xu, D., Wu, Y., Li, W., Fang, T., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1405358 · Cited by 11
Metadata
- Authors
- Fei, H., Yinyin, X., Hui, C., Ni, W., Xin, D., Wei, C., Tao, L., Shitong, H., Miaomiao, S., Mingting, C., Keshavjee, S., Yanlin, Z., Chin, D. P., & Jianjun, L.
- Venue
- The Lancet Regional Health - Western Pacific
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 3
- Pages
- 100032
- ISSN
- 2666-6065 (ISSN-L)
- OpenAlex
- W3087789190
- Cited by
- 112
- References
- 4
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.